Aytu BioPharma, Inc. (AYTU) - Net earnings per share (EPS TTM)

Symbol and logo of brand Aytu BioPharma (AYTU)

Aytu BioPharma, Inc. (AYTU) has completed its management restructuring, shifting its focus toward commercial pharmaceuticals. Earnings per share over the last 12 months confirm this trajectory, where the -1.67 level reflects current efficiency. Physician confidence in ADHD medications ensures stable demand, while a manufacturing outsourcing strategy minimizes capital expenditures, requiring only strict quality control.

AYTU (aytubio.com) Earnings per share for the last 12 months history from 07/04/2022 to 11/16/2026

Comprehensive metric breakdowns and analytics for Aytu Therapeutics (AYTU)

- share price and expert price forecast:
General company analysis:Aytu BioPharma (AYTU)
Mass-produced product of Aytu BioPharma Inc

Long-term investing requires an assessment of earnings sustainability to minimize the risk of capital lock-up. At Aytu BioPharma (AYTU), mature pediatric drugs, which are prone to stagnation, serve as the primary cash generators. The 12-month net income per share trend reflects the final return on each share, adjusted for the impact of the total issuance volume. Growth in this indicator confirms the effectiveness of expense management, while a stable trend here signals the preservation of the business's operational strength.

Competitors of Aytu BioPharma, Inc. (AYTU)

VRTX: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months ALNY|INSM: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months United Therapeutics Corp. (UTHR)|BMRN (BioMarin) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BBIO (BridgeBio)|Earnings per share for the last twelve months bgm.ltd (BGM)|COGT (Cogent Biosciences Inc) - Earnings per share for the trailing year|Earnings per share for the last twelve months Xeris Biopharma Holdings XERS|KROS (Keros Pharma) - Earnings per one share for the last 12 months|Arcturus Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ETON (Eton Pharmaceuticals)|KMDA: Net earnings per share (EPS TTM)|Fulcrum Therapeutics Inc (FULC) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months abeonatherapeutics.com|MREO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PLX|Net earnings per share for the last 12 months Pliant Therapeutics, Inc. PLRX|Net earnings per share (EPS TTM) APLT (Applied Therapeutics Inc.)|Net earnings per share (EPS TTM) Rein Therapeutics Inc. RNTX|gelteq.com - Net earnings per share (EPS TTM)|chemomab.com (CMMB) - Net earnings per share for the last 12 months|SRx Health (SRXH) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Polyrizon Ltd. (PLRZ)|Net earnings per share for the last 12 months AEZS|Net earnings per share for the last 12 months Cyclo Therapeutics Inc. (CYTH)|Net earnings per share for the last 12 months INZY (inozyme.com)|RPHM - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) CSCI (cosciensbio.com)